Literature DB >> 7339783

Pseudomonas cepacia: implications and control of epidemic nosocomial colonization.

W J Martone, C A Osterman, K A Fisher, R P Wenzel.   

Abstract

In the 19-month period January 1979-July 1980, 56 patients became colonized or infected with Pseudomonas cepacia. Three groups of patients were identified. In group I, six otolaryngology patients became colonized when contaminated aqueous cocaine was used as a topical anesthetic. In group II, 24 patients became colonized from contaminated lidocaine normal-saline solutions that had been drawn into syringes in advance (setups) and used during bronchoscopy in the internal medicine department. In group III, the source of colonization of infection for 26 patients with sputum, wound, blood, or urine cultures positive for P. cepacia was not determined. However, contaminated aqueous cocaine, found in the pharmacy, had been given to several of these patients. Since most patients were colonized rather than infected with P. cepacia, there was an apparent disparity in the case count based on data obtained from microbiology records and data obtained from ongoing surveillance of nosocomial infections. Several patients who were merely colonized with P. cepacia were inappropriately treated with chloramphenicol. Successful control measures included sterilizing cocaine solutions in the otolaryngology department and in the pharmacy and eliminating contaminated set-ups in the internal medicine department.

Entities:  

Mesh:

Year:  1981        PMID: 7339783     DOI: 10.1093/clinids/3.4.708

Source DB:  PubMed          Journal:  Rev Infect Dis        ISSN: 0162-0886


  12 in total

1.  Chloramphenicol resistance in Pseudomonas cepacia because of decreased permeability.

Authors:  J L Burns; L A Hedin; D M Lien
Journal:  Antimicrob Agents Chemother       Date:  1989-02       Impact factor: 5.191

Review 2.  The epidemiology of nosocomial epidemic Pseudomonas cepacia infections.

Authors:  W J Martone; O C Tablan; W R Jarvis
Journal:  Eur J Epidemiol       Date:  1987-09       Impact factor: 8.082

3.  Nosocomial infections in intensive care units.

Authors:  F Daschner
Journal:  Intensive Care Med       Date:  1985       Impact factor: 17.440

4.  Salicylate-inducible antibiotic resistance in Pseudomonas cepacia associated with absence of a pore-forming outer membrane protein.

Authors:  J L Burns; D K Clark
Journal:  Antimicrob Agents Chemother       Date:  1992-10       Impact factor: 5.191

5.  Selective medium for Pseudomonas cepacia containing 9-chloro-9-(4-diethylaminophenyl)-10-phenylacridan and polymyxin B sulfate.

Authors:  B J Wu; S T Thompson
Journal:  Appl Environ Microbiol       Date:  1984-10       Impact factor: 4.792

6.  Pseudomonas cepacia adherence to respiratory epithelial cells is enhanced by Pseudomonas aeruginosa.

Authors:  L Saiman; G Cacalano; A Prince
Journal:  Infect Immun       Date:  1990-08       Impact factor: 3.441

7.  Cervical osteomyelitis caused by Pseudomonas cepacia in an intravenous-drug abuser.

Authors:  M A Smith; N R Trowers; R S Klein
Journal:  J Clin Microbiol       Date:  1985-03       Impact factor: 5.948

8.  Pulmonary clearance and inflammatory response in C3H/HeJ mice after intranasal exposure to Pseudomonas spp.

Authors:  S E George; M J Kohan; M I Gilmour; M S Taylor; H G Brooks; J P Creason; L D Claxton
Journal:  Appl Environ Microbiol       Date:  1993-11       Impact factor: 4.792

9.  Pseudomonas cepacia colonization and infection in intensive care units.

Authors:  J M Conly; L Klass; L Larson; J Kennedy; D E Low; G K Harding
Journal:  CMAJ       Date:  1986-02-15       Impact factor: 8.262

10.  Serological classification of Pseudomonas cepacia by somatic antigen.

Authors:  Y Nakamura; S Hyodo; E Chonan; S Shigeta; E Yabuuchi
Journal:  J Clin Microbiol       Date:  1986-07       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.